骨氏葆方治疗肾虚血瘀型膝重度骨关节炎的临床研究

任伟亮; 朱艳风; 韩昆; 于健; 胡志勇; 刘士诚; 王金榜; 田雅峰; 齐立卿

骨氏葆方治疗肾虚血瘀型膝重度骨关节炎的临床研究

河北省中医院骨伤二科，河北石家庄 050011

计量
- 文章访问数: 660
- HTML全文浏览量: 11
- PDF下载量: 651
- 被引次数: 0
出版历程
- 收稿日期: 2015-10-07
- 修回日期: 2015-11-20
- 刊出日期: 2016-03-10

Clinical Research of Gushibao Pill on Severe Kidney Circulation Deficiency and Blood Stasis Type Knee Osteoarthritis

摘要

摘要: 目的观察骨氏葆方治疗肾虚血瘀型膝重度骨关节炎的临床疗效及安全性。方法选取70例肾虚血瘀型膝重度骨关节炎患者为研究对象，其中治疗组38例和对照组32例，2组患者均给予健康教育和膝关节内粘疗法等基础治疗，对照组予盐酸氨基葡萄糖胶囊口服，治疗组予骨氏葆方口服，共治疗5周。在治疗前后采用骨关节炎指数量表（WOMAC）及膝骨关节炎严重程度指数量表（ISOA）评价患者治疗效果，采用中医症状评分标准对患者的临床症状进行评分，并监测治疗前后患者血沉、降钙素（CT）及骨型碱性磷酸酶（BALP）的变化情况。结果与治疗前比较，2组患者血沉明显下降（P＜0.01），治疗组低于对照组（P<0.05），降钙素及骨型碱性磷酸酶无显著变化（P＞0.05）；2组患者症状、体征积分均显著下降(P<0.01)，治疗组下降程度显著大于对照组（P＜0.01）；2组患者疼痛评分、WOMAC评分及ISOA评分均明显降低（P＜0.01），治疗组低于对照组（P＜0.01）；治疗组总有效率为97.37%，显著高于对照组总有效率(80.00%)，P＜0.05。2组患者在治疗过程中均无出现明显不良反应。结论骨氏葆方可降低肾虚血瘀型膝重度骨关节炎患者的血沉，能够有效改善患者临床症状。
- 骨氏葆方 /
- 膝骨关节炎 /
- 临床疗效
Abstract: OBJECTIVE To observe the clinical effect and safety of treatment of Gushibao pill on severe kidney circulation deficiency and blood stasis type knee osteoarthritis. METHODS 70 patients with severe knee osteoarthritis were selected for this study， and were divided into the treatment group (38 cases) and the control group (32 cases). Patients of two groups were given health education and basic knee stick therapy treatment. On the basis of basic treatment， patients in the control group were given glucosamine hydrochloride capsules orally and treatment group were give Gubaoshi pill. WOMAC Osteoarthritis Index Scale and ISOA knee osteoarthritis severity index scale were used to evaluate the outcomes of two groups. Chinese medicine symptom score were used to evaluate the clinical symptoms. ESR， calcitonin (CT) and bone alkaline phosphatase (BALP) were detected before and after treatment. RESULTS Erythrocyte sedimentation rate in the control group significantly decreased after a course of treatment (P<0.05)， and bone alkaline phosphatase and calcitonin showed no significant change(P>0.05). Erythrocyte sedimentation rate decreased significantly in treatment group after treatment (P<0.05)， and bone alkaline phosphatase and calcitonin showed no significant change (P>0.05). Scored of symptoms and signs significantly decreased in two groups， and the decreased extent of treatment group was significantly greater than that of the control group (P<0.05). Pain score， WOMAC score and ISOA scores were significantly lower in two groups of patients compared with the condition before treatment (P<0.05). After treatment， pain score， WOMAC score and ISOA scores of treatment group were lower than those of the control group (P<0.05). The total effective rate of treatment group was 97.37%， and was significantly higher than the control group (80.00%). The difference was statistically significant (P<0.05). Two patients had no obvious adverse reactions during treatment. CONCLUSION Gushibao pill can decrease the level of erythrocyte sedimentation rate in patients with severe kidney circulation deficiency and blood stasis knee osteoarthritis. It is effective and safe.
- Gushibao pill /
- knee osteoarthritis /
- clinical efficacy

HTML全文

参考文献(16)

[1]	Roos EM， Arden NK. Strategies for the prevention of knee osteoarthritis[J]. Nat Rev Rheumatol， 2016，12（2）：92-101.
[2]	闫子贵，马纯青，韩勇，等．人工膝关节表面置换治疗重度骨性关节炎疗效分析[J]．中国伤残医学，2013，21（9）：3-5．
[3]	Yan ZG， Ma CQ， Han Y， et al. The clinical effects of artif cial total knee replacement in patients with severe oseto arthrtiis[J]. Chin J Trauma Disab Med， 2013，21(9): 3-5.
[4]	严培军，王培民．周福贻教授从痰瘀论治膝关节骨性关节炎的经验[J]．南京中医药大学学报，2013， 29（1）：84-86．
[5]	Yan PJ， Wang PM. Professor Zhou fu-yi's experience of treating knee osteoarthritis from resolving phlegm and blood stasis[J]. J Nanjing Univ Tradit Chin Med， 2013， 29(1): 84-86.
[6]	Skou ST， Roos EM， Simonsen O， et al. The efficacy of non-surgical treatment on pain and sensitization in patients with knee osteoarthritis: a pre-defined ancillary analysis from a randomized controlled trial[J]. Osteoarthritis Cartilage， 2016， 24（1）：108-116.
[7]	中华医学会风湿病学分会．骨关节炎诊断及治疗指南[J]．中华风湿病学杂志，2010， 14（6）：416-419．
[8]	Rheumatology branch of Chinese medical association. Diagnosis and treatment guidelines of osteoarthritis[J]. Chin J Rheumatol， 2010， 14(6): 416-419．
[9]	中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002: 356-360．
[10]	Clinical guideline of new drugs for traditional Chinese medicine[M]. Beijing: China medical science press， 2002: 356-360.
[11]	刘晓亭，李春日，董宝强．3种热疗法治疗膝骨关节炎的临床疗效比较[J]．南京中医药大学学报，2012， 28（4）：315-317．
[12]	Liu XT， Li CR， Dong BQ. Clinical study of 3 thermotherapies for knee osteoarthritis[J]. J Nanjing Univ Tradit Chin Med， 2012， 28(4): 315-317.
[13]	黎沛裕，陈海鹏，丘宏龙．原发性膝骨关节炎中医治疗研究进展[J]．中医研究，2014， 27（11）：72-75．
[14]	Li PY， Chen HP， Qiu HL. Research progress of primary knee osteoarthritis treatment by TCM[J]. Tradit Chin Med Res， 2014， 27(11): 72-75.
[15]	李肇端，周汾，王曼，等．关节腔内注射消炎镇痛液复合玻璃酸钠治疗膝关节炎[J]．中国中西医结合外科杂志，2013，19（5）：583-585．
[16]	Li ZD， Zhou F， Wang M， et al. The treatment of osteoarthritis by intra-articular injection of anti-inflammatory analgesic liquid compound sodium hyaluronate[J]. Chin J Surg Integr Tradit West Med， 2013，19(5):583-585.